2m 2m 2m 2m 2m 2m 2m
AQUESTIVE THERP (AQST)
NASDAQ
$5.05+$0.01 (+0.30%)
Price as of Jun 23, 2026 7:47 PM EDT- $592.1MMarket Cap
- 43.47%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
AQUESTIVE THERP (AQST)
$5.05+$0.01 (+0.30%)
AQST | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.03 | ||
Change | +$0.010 (+0.21%) | ||
Open | $4.71 | ||
High | $5.11 | ||
Low | $4.71 | ||
Previous Close | $4.72 | ||
Volume | 2,988,647 | ||
30-Day Average Volume | 1,604,400 | ||
1-Week Change | 11.85% | ||
1-Month Change | 14.56% | ||
1-Year Change | 43.47% | ||
3-Year Change | 149.74% | ||
5-Year Change | 13.73% | ||
Fundamentals | |||
Shares Outstanding | 125.5M | ||
Total Assets | $141.1M | ||
Market Cap | $592.1M | ||
Enterprise Value | $520.2M | ||
Period: QTR TTM FY | |||
Revenue | $500,000.00 | ||
Net Income | -$8.1M | ||
Free Cash Flow | -$14.9M | ||
EBIT | -$8.1M | ||
EBITDA | -$7.9M | ||
Net Working Capital | $98.4M | ||
EPS | -$0.07 | ||
Enterprise Value/EBITDA | -65 | ||
Enterprise Value/Revenue | 1,040 | ||
P/B | -17 | ||
P/E | -67 | ||
PEG | -1 | ||
Price/Free Cash Flow | -40 | ||
Price/Operating Cash Flow | -40 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue